Department of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan, Taiwan.
Department of Optometry, Chung Hwa Medical University, Tainan, Taiwan.
Medicine (Baltimore). 2022 Jul 22;101(29):e29697. doi: 10.1097/MD.0000000000029697.
Diabetes mellitus (DM) was found to be more common in hepatitis C virus (HCV)-related cirrhotic males. However, the association between DM, or other extrahepatic manifestations (EHMs), and liver cirrhosis is still undetermined. We used a large-scale long-term study to analyze the cirrhosis risk of treatment-naïve HCV patients with EHMs as compared to those without. In this retrospective nested case-control study, we identified 11 872 treatment-naïve patients with chronic HCV between 2001 and 2013 from Taiwan National Health Insurance Research Database and divided them into patients with (cases) and without cirrhosis (controls). All patients were followed up from the index month (exact month of diagnosis) to the end of 2013, death, or study outcome, whichever occurred first. The cases and controls were 1:6 propensity score matched for age, sex, and exact month of diagnosis; finally, 8078 patients (1154 with and 6924 without cirrhosis) were included in the analysis. The presence of coexisting EHMs and a new diagnosis of cirrhosis was analyzed. Adjusted hazard ratios (HRs) and cumulative incidence for cirrhosis were calculated in conditional Cox regression models after propensity score matching. Patients with high-cirrhosis-risk EHMs, such as DM (HR: 1.72, 95% CI: 1.51-1.96, P < .001), HCD (HR: 1.45, 95% CI: 1.27-1.67, P < .007), CKD (HR: 1.21, 95% CI: 1.05-1.38, P < .001), hyperlipidemia (HR: 0.53, 95% CI: 0.46-0.60, P < .001), lichen planus (HR: 2.71, 95% CI: 1.56-4.72, P < .001), and palpable purpura (HR: 2.67, 95% CI: 2.13-3.35, P < .001) exhibited significantly higher risk of liver cirrhosis than those without. Cumulative incidence (P < .001) of liver cirrhosis by pairwise comparisons of multiple high-cirrhosis-risk EHMs, and that of lichen planus was the highest. Our study provided direct estimates of specific HCV-associated EHM time trends of cirrhosis risk, with an upward trend in incidence. Lichen planus was at the top of the list of single-EHM comparisons, and the maximum combination of certain EHMs was the greatest risk factor across a different array of multi-EHM comparisons for liver cirrhosis development.
糖尿病(DM)在丙型肝炎病毒(HCV)相关肝硬化男性中更为常见。然而,DM 或其他肝外表现(EHMs)与肝硬化之间的关联仍未确定。我们使用大规模长期研究来分析治疗初治 HCV 患者 EHMs 与无 EHMs 患者的肝硬化风险。在这项回顾性巢式病例对照研究中,我们从台湾全民健康保险研究数据库中确定了 2001 年至 2013 年间 11872 例治疗初治慢性 HCV 患者,并将其分为肝硬化患者(病例)和无肝硬化患者(对照)。所有患者均从索引月(诊断的确切月份)开始随访至 2013 年底、死亡或研究结果出现(以先发生者为准)。对年龄、性别和诊断的确切月份进行 1:6 的倾向评分匹配;最终,8078 例患者(1154 例有肝硬化,6924 例无肝硬化)纳入分析。分析了共存 EHMs 的存在和新诊断的肝硬化。在倾向评分匹配后,采用条件 Cox 回归模型计算肝硬化的调整后的危险比(HR)和累积发病率。具有高肝硬化风险的 EHMs 患者,如糖尿病(HR:1.72,95%CI:1.51-1.96,P<.001)、HCV 相关肾小球肾炎(HR:1.45,95%CI:1.27-1.67,P<.007)、CKD(HR:1.21,95%CI:1.05-1.38,P<.001)、高脂血症(HR:0.53,95%CI:0.46-0.60,P<.001)、扁平苔藓(HR:2.71,95%CI:1.56-4.72,P<.001)和可触及紫癜(HR:2.67,95%CI:2.13-3.35,P<.001),与无 EHMs 患者相比,肝硬化风险显著增加。通过多个高肝硬化风险 EHMs 的两两比较的累积发病率(P<.001),以及扁平苔藓的累积发病率最高。我们的研究提供了特定 HCV 相关 EHM 肝硬化风险时间趋势的直接估计,发病率呈上升趋势。在单一 EHM 比较中,扁平苔藓位居榜首,而某些 EHMs 的最大组合在不同的多 EHM 比较中是肝硬化发展的最大危险因素。